• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I期睾丸肿瘤的治疗

Treatment of stage I testicular tumours.

作者信息

Germa Lluch J R, Climent M A, Villavicencio H, Gomez de Segura G, Blanco R, Mercedes A, de Andres L, Sole Balcells F J

机构信息

Medical Oncology Unit, Hospital Santa Creu i Sant Pau, Barcelona, Spain.

出版信息

Br J Urol. 1993 Apr;71(4):473-7. doi: 10.1111/j.1464-410x.1993.tb15996.x.

DOI:10.1111/j.1464-410x.1993.tb15996.x
PMID:8499994
Abstract

Between 1980 and 1989, 138 patients with stage I carcinoma of the testes were treated and followed up; 81 patients had seminoma and 57 had non-seminomatous tumours. Between January 1980 and December 1983, patients with seminoma were treated by orchiectomy, followed by complementary radiotherapy to aortic and ipsilateral pelvic nodes. Retroperitoneal lymph node dissection (RPLND) was performed in patients with non-seminomatous tumours. After January 1984 the treatment strategy was changed and orchiectomy was followed by a surveillance policy in all histological types. In seminoma patients, 1 of 36 patients (3%) treated with complementary radiotherapy and 5 of 45 (11%) on the surveillance policy relapsed. All achieved a complete response after chemotherapy. In non-seminomatous tumours, 3 of 21 patients (14%) treated with complementary lymphadenectomy relapsed, in contrast to 11 of 36 (31%) surveillance policy patients. All patients who relapsed obtained a complete response with chemotherapy. All patients are currently free of disease. There were no differences in survival between both treatment policies. We conclude that a wait and see policy in stage I testicular tumours is feasible and provides the same results as more interventionist practices.

摘要

1980年至1989年间,对138例睾丸I期癌患者进行了治疗和随访;其中81例为精原细胞瘤患者,57例为非精原细胞瘤患者。1980年1月至1983年12月期间,精原细胞瘤患者接受睾丸切除术,随后对主动脉和同侧盆腔淋巴结进行辅助放疗。非精原细胞瘤患者则进行腹膜后淋巴结清扫术(RPLND)。1984年1月以后,治疗策略发生了改变,所有组织学类型的患者在睾丸切除术后均采取监测策略。在精原细胞瘤患者中,接受辅助放疗的36例患者中有1例(3%)复发,采取监测策略的45例患者中有5例(11%)复发。所有复发患者在化疗后均实现完全缓解。在非精原细胞瘤患者中,接受辅助淋巴结清扫术的21例患者中有3例(14%)复发,而采取监测策略的36例患者中有11例(31%)复发。所有复发患者经化疗后均实现完全缓解。目前所有患者均无疾病。两种治疗策略的生存率无差异。我们得出结论,对I期睾丸肿瘤采取观望策略是可行的,并且与更多干预性治疗方法的效果相同。

相似文献

1
Treatment of stage I testicular tumours.I期睾丸肿瘤的治疗
Br J Urol. 1993 Apr;71(4):473-7. doi: 10.1111/j.1464-410x.1993.tb15996.x.
2
[Urologic treatment of testicular germ cell cancer].睾丸生殖细胞癌的泌尿外科治疗
Arch Esp Urol. 2002 Oct;55(8):927-36.
3
[Therapeutic indications for germinal testicular tumors].[睾丸生殖细胞肿瘤的治疗指征]
Ann Urol (Paris). 1992;26(2):119-24.
4
[Treatment of subdiaphragmatic lymph node metastases of primary testicular seminoma (stage II)].
Radiol Med. 1989 Jan-Feb;77(1-2):104-14.
5
Radiation therapy of early (stages I and II-A) seminoma of testis after initial orchiectomy.睾丸早期(I期和II - A期)精原细胞瘤在初次睾丸切除术后的放射治疗。
Urology. 1990 Nov;36(5):390-4. doi: 10.1016/s0090-4295(90)80281-q.
6
Testicular tumors of germ cell origin.
Postgrad Med. 1981 Dec;70(6):125-7, 130-1. doi: 10.1080/00325481.1981.11715938.
7
Therapy in stage I non-seminomatous testicular tumor. A critical review of current strategies.I期非精原细胞瘤性睾丸肿瘤的治疗。对当前策略的批判性综述。
Eur Urol. 1984;10(1):1-9. doi: 10.1159/000463502.
8
Surveillance or lymph node dissection in clinical stage I non-seminomatous germinal testis cancer?临床I期非精原性生殖细胞睾丸癌应进行监测还是淋巴结清扫?
Br J Urol. 1985 Dec;57(6):759-62. doi: 10.1111/j.1464-410x.1985.tb07049.x.
9
[Surveillance after orchiectomy for stage I testicular seminoma].
Nihon Hinyokika Gakkai Zasshi. 1992 Nov;83(11):1789-94. doi: 10.5980/jpnjurol1989.83.1789.
10
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.睾丸精原细胞瘤晚期疾病的管理。14例报告及文献复习。
Arch Ital Urol Androl. 2002 Jun;74(2):81-5.

引用本文的文献

1
Clinical stage I seminoma: the case for surveillance.临床I期精原细胞瘤:监测的理由。
World J Urol. 2009 Aug;27(4):433-9. doi: 10.1007/s00345-009-0430-0. Epub 2009 Jun 11.
2
Treatment of stage I testicular germ-cell tumors.I 期睾丸生殖细胞肿瘤的治疗。
Med Oncol. 2006;23(3):305-15. doi: 10.1385/MO:23:3:305.
3
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?在一个计算机断层扫描资源有限且地域广阔的国家,组织学低危非精原细胞瘤性睾丸癌患者的监测安全性如何?
Br J Cancer. 1994 Dec;70(6):1156-60. doi: 10.1038/bjc.1994.464.